Solano SSR, Maldonado MEP

Language: Spanish
References: 14
Page: 104-109
PDF size: 298.25 Kb.

ABSTRACT

Background: Dyspareunia is defined as a complaint of persistent or recurrent pain or discomfort associated with attempted or complete vaginal penetration during sexual activity. The pelvic floor muscles play an important physiological processes in the role of voiding, defecation and sexual function. Overactivity can lead to various disorders as dysfunctional voiding or defecation, pelvic pain and sexual dysfunction such as dyspareunia. There is a difference in the electromyographic in women diagnosed with superficial dyspareunia before and after treatment with pelvic floor rehabilitation. Method: Intra-group clinical trial. Women with superficial dyspareunia received pelvic floor rehabilitation with transcutaneous electrical nerve stimulation. Electromyographic was assessed before and after treatment. Results: 16 women with superficial dyspareunia were studied. Statistical technique T test for independent samples was used. Intra-group differences were statistically significant. Conclusion: Transcutaneous electrical nerve stimulation is an effective rehabilitation technique for the treatment of superficial dyspareunia.

REFERENCES

1. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin No. 119: Female sexual dysfunction. Obstet Gynecol. 2011; 117 (4): 996-1007.

2. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010; 21 (1): 5-26.

3. Bharucha AE, Trabuco E. Functional and chronic anorectal and pelvic pain disorders. Gastroenterol Clin North Am. 2008; 37 (3): 685-696.

4. Seehusen DA, Baird DC, Bode DV. Dyspareunia in women. Am Fam Physician. 2014; 90 (7): 465-470.

5. Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012; 87 (2): 187-193.

6. Butrick CW. Pathophysiology of pelvic floor hypertonic disorders. Obstet Gynecol Clin North Am. 2009; 36 (3): 699-705.

7. Glazer HI, Romanzi L, Polaneczky M. Pelvic floor muscle surface electromyography. Reliability and clinical predictive validity. J Reprod Med. 1999; 44 (9): 779-782.

8. FitzGerald MP, Kotarinos R. Rehabilitation of the short pelvic floor, II: treatment of the patient with the short pelvic floor. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14 (4): 269-275.

9. Tu FF, As-Sanie S, Steege JF. Musculoskeletal causes of chronic pelvic pain: a systematic review of existing therapies: part II. Obstet Gynecol Surv. 2005; 60 (7): 474-483.

10. Wehbe SA, Fariello JY, Whitmore K. Minimally invasive therapies for chronic pelvic pain syndrome. Curr Urol Rep. 2010; 11 (4): 276-285.

11. Araujo JE, Jármy Di Bella ZI, Diniz ZMR, Poli AM, Dellabarba PC, Martins WP et al. Assessment of pelvic floor of women runners by three-dimensional ultrasonography and surface electromyography. A pilot study. Med Ultrason. 2014; 16 (1): 21-26.

12. Klingele CJ, Lightner DJ, Fletcher JG, Gebhart JB, Bharucha AE. Dysfunctional urinary voiding in women with functional defecatory disorders. Neurogastroenterol Motil. 2010; 22 (10): 1094-e284.

13. Dionisi B, Anglana F, Inghirami P, Lippa P, Senatori R. Use of transcutaneous electrical stimulation and biofeedback for the treatment of vulvodynia (vulvar vestibular syndrome): result of 3 years of experience. Minerva Ginecol. 2008; 60 (6): 485-491.

14. Dionisi B, Senatori R. Effect of transcutaneous electrical nerve stimulation on the postpartum dyspareunia treatment J Obstet Gynaecol Res. 2011; 37 (7): 750-753.